CareDx Inc (CDNA)
CareDx Inc Statistics
Share Statistics
CareDx Inc has 55.43M shares outstanding. The number of shares has increased by 3.58% in one year.
Shares Outstanding | 55.43M |
Shares Change (YoY) | 3.58% |
Shares Change (QoQ) | 1.69% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 51.94M |
Failed to Deliver (FTD) Shares | 12.8K |
FTD / Avg. Volume | 1.5% |
Short Selling Information
The latest short interest is 4.39M, so 8.18% of the outstanding shares have been sold short.
Short Interest | 4.39M |
Short % of Shares Out | 8.18% |
Short % of Float | 8.74% |
Short Ratio (days to cover) | 5.27 |
Valuation Ratios
The PE ratio is 21.5 and the forward PE ratio is 40.07. CareDx Inc's PEG ratio is -0.17.
PE Ratio | 21.5 |
Forward PE | 40.07 |
PS Ratio | 3.39 |
Forward PS | 1.8 |
PB Ratio | 2.99 |
P/FCF Ratio | 29.7 |
PEG Ratio | -0.17 |
Enterprise Valuation
CareDx Inc has an Enterprise Value (EV) of 597.2M.
EV / Earnings | 11.36 |
EV / Sales | 1.79 |
EV / EBITDA | -17.57 |
EV / EBIT | 14.65 |
EV / FCF | 15.7 |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.06.
Current Ratio | 3.94 |
Quick Ratio | 3.72 |
Debt / Equity | 0.06 |
Total Debt / Capitalization | 5.56 |
Cash Flow / Debt | 1.71 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.14% and return on capital (ROIC) is 10.11%.
Return on Equity (ROE) | 0.14% |
Return on Assets (ROA) | 0.11% |
Return on Capital (ROIC) | 10.11% |
Revenue Per Employee | $518,299.69 |
Profits Per Employee | $81,597.83 |
Employee Count | 644 |
Asset Turnover | 0.68 |
Inventory Turnover | n/a |
Taxes
Income Tax | 310K |
Effective Tax Rate | 0.01 |
Stock Price Statistics
The stock price has increased by 73.65% in the last 52 weeks. The beta is 1.95, so CareDx Inc's price volatility has been higher than the market average.
Beta | 1.95 |
52-Week Price Change | 73.65% |
50-Day Moving Average | 21.44 |
200-Day Moving Average | 23.04 |
Relative Strength Index (RSI) | 40.12 |
Average Volume (20 Days) | 854.19K |
Income Statement
In the last 12 months, CareDx Inc had revenue of 333.79M and earned 52.55M in profits. Earnings per share was 1.
Revenue | 333.79M |
Gross Profit | 333.79M |
Operating Income | 40.77M |
Net Income | 52.55M |
EBITDA | -33.99M |
EBIT | 40.77M |
Earnings Per Share (EPS) | 1 |
Balance Sheet
The company has 114.69M in cash and 22.26M in debt, giving a net cash position of 92.43M.
Cash & Cash Equivalents | 114.69M |
Total Debt | 22.26M |
Net Cash | 92.43M |
Retained Earnings | -626.24M |
Total Assets | 491.05M |
Working Capital | 262.46M |
Cash Flow
In the last 12 months, operating cash flow was 38.05M and capital expenditures 0, giving a free cash flow of 38.05M.
Operating Cash Flow | 38.05M |
Capital Expenditures | 0 |
Free Cash Flow | 38.05M |
FCF Per Share | 0.72 |
Margins
Gross margin is 100%, with operating and profit margins of 12.21% and 15.74%.
Gross Margin | 100% |
Operating Margin | 12.21% |
Pretax Margin | 15.84% |
Profit Margin | 15.74% |
EBITDA Margin | -10.18% |
EBIT Margin | 12.21% |
FCF Margin | 11.4% |
Dividends & Yields
CDNA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 5.44% |
FCF Yield | 3.73% |
Analyst Forecast
The average price target for CDNA is $33.5, which is 82.2% higher than the current price. The consensus rating is "Buy".
Price Target | $33.5 |
Price Target Difference | 82.2% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Scores
Altman Z-Score | 5.48 |
Piotroski F-Score | 5 |